戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s on cells that are otherwise insensitive to inhibin.
2 unctional interactions with both activin and inhibin.
3 itive model for the antagonism of activin by inhibin.
4 nized by endocrine acting, gonadally derived inhibin.
5 ct and often opposed actions of TGFbetas and inhibins.
6 32] ng/mL, p < 0.001; pro alpha C-containing inhibins 2.2 [0.81] vs 0.71 [0.33] ng/mL, p < 0.001).
7                    Molecular-weight forms of inhibin A (32 kDa) and activin A (> 100 kDa) were simila
8 g receptors and is additionally required for inhibin A (InhA) activity.
9 g growth factor-beta (TGF-beta) isoforms and inhibin A (InhA) to enable temporal-spatial patterns of
10 -eclampsia than in control normal pregnancy (inhibin A 3.05 [1.8] vs 0.36 [0.14] ng/mL, p < 0.001; ac
11 nd binding using iodinated recombinant human inhibin A and 125I-labeled recombinant human inhibin A.
12                                              Inhibin A and activin A are produced by the placenta dur
13 sh the molecular-weight forms of circulating inhibin A and activin A in pre-eclampsia.
14 ysis to assess the molecular-weight forms of inhibin A and activin A.
15                                              Inhibin A and B are TGFbeta proteins that suppress FSH s
16                                     Although inhibin A and B binding was 20-fold lower compared with
17 ng of follicle-stimulating hormone (FSH) and inhibin A and B levels.
18 ls of activin A, activin B, alpha-subunit of inhibin A and B proteins, and the antagonists follistati
19                       Astrocyte secretion of Inhibin A and downregulation of oligodendrocyte precurso
20 onic gonadotropin, unconjugated estriol, and inhibin A at 15 through 18 weeks of gestation).
21 contrast, infusion of the activin antagonist inhibin A did not influence behavior but blocked the eff
22  Matrilin-2 induces OPC differentiation, and Inhibin A inhibits OPC Matrilin-2 expression and inhibit
23                                              Inhibin A is induced in reactive astrocytes after stroke
24 sitively correlated with a high activin A to inhibin A ratio.
25 pe III receptor, betaglycan, is required for inhibin A suppression of FSH.
26                      Serum concentrations of inhibin A, activin A, and pro alpha C were significantly
27                                 Biotinylated inhibin A, but not activin A, bound ALK4.
28 ular niche where reactive astrocytes secrete Inhibin A, downregulating Matrilin-2 and blocking myelin
29 ines (granulocyte colony-stimulating factor, inhibin A, Epstein-Barr virus-induced gene 3, interleuki
30              Serum samples were analysed for inhibin A, inhibin B, pro alpha C, and activin A.
31      Higher maternal serum concentrations of inhibin A, pro alpha C, and total activin A in pre-eclam
32 med to measure circulating concentrations of inhibin A, pro alpha C-containing inhibins, and activin
33 ifies several candidate molecules, including Inhibin A-a negative regulator of Matrilin-2.
34 lion and trigeminal ganglion-bound iodinated inhibin A.
35 inhibin A and 125I-labeled recombinant human inhibin A.
36 okeratins 8 and 19, and the absence of alpha-inhibin, a protein characteristically expressed in norma
37  via a distinct site, but are unable to bind inhibin-A.
38                                              Inhibin abrogates BMP-induced Smad signaling and transcr
39 ta expand our understanding of how endocrine inhibin achieves potent antagonism of local, constitutiv
40 ivins, which are structurally related to the inhibins, act within the pituitary to stimulate FSH prod
41              These findings demonstrate that inhibin, acting through betaglycan, can function as an a
42  that additional components are required for inhibin action.
43 pression profiling has uncovered a defective inhibin-activin signaling pathway in TAFII105-deficient
44 detailed immunohistochemical localization of inhibin/activin alpha-, beta A-, and beta B-subunits thr
45 receptors (alone and in combination) for the inhibin/activin subfamily, we developed a cell-free assa
46                4) mRNAs encoding each of the inhibin/activin subunits are expressed in all major brai
47 ogenase, luteinization hormone receptor, and inhibin/activin subunits.
48 y evidence to suggest that regulation of the inhibin/activin system is essential for early folliculog
49 ive inhibin receptors were isolated using an inhibin affinity column.
50  superfamily members, TGF-beta, activin, and inhibin, all have prominent roles in regulating normal o
51 rum testosterone levels and intra-testicular inhibin alpha and inhibin beta B levels are not altered
52  activation of Fshb inhibitory factors (e.g. inhibin alpha and VGF nerve growth factor-inducible), 2)
53 ca cells may contribute significantly to the inhibin alpha content of FF and peripheral blood.
54                           However, exogenous inhibin alpha did not raise androgen production.
55                   Targeted disruption of the inhibin alpha gene (Inha(-)(/)(-)) in mice results in an
56 n Inha(-)(/)(-) mice, which demonstrate that inhibin alpha has important consequences upon follicle d
57                         We hypothesised that inhibin alpha may modulate the opposing effects of BMP a
58 e findings suggest a positive role of thecal inhibin alpha on androgen production.
59 lls show abundant INHA expression and 'free' inhibin alpha production.
60            Role(s), if any, played by thecal inhibin alpha remain elusive.
61                                   Absence of inhibin alpha resulted in advanced follicular maturation
62 ction while INSL3 knockdown reduced INHA and inhibin alpha secretion.
63 zed heifers, casting further doubt on thecal inhibin alpha subunit having a significant role in modul
64 o activation of serum glucocorticoid kinase, inhibin alpha, and c-fos genes.
65                Activin stimulates endogenous inhibin alpha- and betaB-subunit mRNA, protein, and prot
66  concentrations differed between control and inhibin alpha-immunized heifers, casting further doubt o
67                                          The inhibin alpha-subunit mature domain (N terminus) arose r
68 stromal tumors, derived from male and female inhibin alpha-subunit-deficient mice, were also identifi
69 iated with ACC, including SF-1, Melan A, and inhibin alpha.
70 with the p215-234 peptide derived from mouse inhibin-alpha activates CD4(+) T cells and induces exper
71  muscle layers, and lower immunostaining for inhibin-alpha and follistatin.
72                                          Our inhibin-alpha autoimmune model of POF shows how prematur
73 tive FOXO1 mutant also suppressed cyclin D2, inhibin-alpha, and epiregulin promoter-reporter activiti
74 p-regulation of reporter activities for LHR, inhibin-alpha, and vascular endothelial growth factor is
75  mutant to attenuate induction of cyclin D2, inhibin-alpha, aromatase, SCC, SF-1, and epiregulin.
76  enhanced expression of cyclin D2 as well as inhibin-alpha, aromatase, steroidogenic factor-1 (SF-1),
77 ncluding luteinizing-hormone receptor (LHR), inhibin-alpha, microtubule-associated protein 2D, and th
78 uppressed induction of cyclin D2, aromatase, inhibin-alpha, SF-1, and epiregulin.
79 h1 T cells that stimulate B cells to produce inhibin-alpha-neutralizing Abs directly capable of media
80      Affected mice show high serum levels of inhibin-alpha-neutralizing Abs that prevent inhibin-medi
81                                        Thus, inhibin-alpha-targeted experimental autoimmune oophoriti
82                                              Inhibin also binds type II activin receptors and antagon
83                                              Inhibin also forms crosslinked complexes with both recom
84                                              Inhibins also bind type II activin receptors but do not
85                                              Inhibin and activin are best known as gonadal glycoprote
86                                              Inhibin and activin are members of the transforming grow
87 m pituitary gonadotrope cells, and together, inhibin and activin control the pituitary gonadal axis e
88             The results suggest that central inhibin and activin proteins are produced in the brain w
89 BMP responses, suggesting a broader role for inhibin and betaglycan in restricting and refining a wid
90                                     Abundant inhibin and few activin binding sites were identified in
91     Mutation of Val614 to Tyr abolishes both inhibin and TGFbeta binding to this domain.
92 the co-receptor actions of betaglycan toward inhibin and TGFbeta will allow the clarification of the
93                             We show that the inhibin and TGFbeta-binding residues of this domain over
94 ically enhances the antimigratory effects of inhibin and the ability of inhibin to repress matrix met
95 transforming growth factor beta superfamily, inhibins and activins are a physiologically relevant pai
96                                              Inhibins and activins are dimeric proteins that are func
97                                              Inhibins and activins are members of the transforming gr
98      Betaglycan mediates the actions of both inhibins and is broadly expressed.
99  as a cell surface receptor and mediate BMP, inhibin, and TGF-beta signaling suggests a broader role
100 rations of inhibin A, pro alpha C-containing inhibins, and activin A in the serum of women with pre-e
101 eta) superfamily includes TGFbeta, activins, inhibins, and bone morphogenetic proteins (BMPs).
102      The ability of betaglycan to facilitate inhibin antagonism of activin provides a variation on th
103     These betaglycan mutants fail to mediate inhibin antagonism of activin signaling but can present
104 eceptor binding and activity, as well as for inhibin antagonism of activin through its receptors.
105 recise structural aspects that contribute to inhibin antagonism of activin.
106  and ActRIB or ActRIB only, we show that the inhibin antagonistic effects on activin-induced biologic
107                                              Inhibins are endogenous antagonists of activin signaling
108                                          The inhibins are gonadal transforming growth factor beta sup
109                                              Inhibins are ovarian dimeric glycoprotein hormones that
110 anti-Mullerian hormone (AMH; women only) and inhibin B (men only), frequencies of pregnancies, and in
111 kdown or overexpression abrogates or confers inhibin B activity in cells.
112  decrease in antimullerian hormone (AMH) and inhibin B and an increase in FSH with age corresponding
113 lysis was performed to determine the optimal inhibin B and FSH values for identifying patients with a
114 Klotho levels had significantly higher serum Inhibin B and total sperm count than men with the lowest
115 MH), follicle-stimulating hormone (FSH), and inhibin B and urinary level of FSH.
116 ls of follicle-stimulating hormone (FSH) and inhibin B are correlated with sperm concentration, their
117                                TGFBR3L binds inhibin B but not other TGFB family ligands.
118                                          The inhibin B co-receptor was previously unknown.
119 ansmembrane protein, TGFBR3L, is the elusive inhibin B co-receptor.
120 7+/-0.7 nmol per liter], P=0.004), and serum inhibin B concentrations (119+/-52 vs. 60+/-21 pg per mi
121                                              Inhibin B concentrations in maternal serum were not incr
122                                      AMH and inhibin B concentrations were generally higher in the Br
123 n the non-azoospermic cancer survivor group, inhibin B concentrations were lower than in controls (me
124 on of bioactive mature activin B, as well as inhibin B dimers, necessary for local follicle-stimulati
125 ocytosis may have had resulted in changes in inhibin B expression.
126 alues, the specificity of the serum level of inhibin B for identifying azoospermic survivors was 45.0
127 sate for the absence of activin B and AB and inhibin B in the process of mammogenesis.
128 evels (LR+ 3.06; 95% CI, 2.06-4.54), and low inhibin B levels (LR+ 2.05; 95% CI, 0.96-4.39).
129                                              Inhibin B levels (n = 737) were not associated with the
130 jury that caused diminished testosterone and inhibin B levels and oligospermia.
131 ulating hormone, anti-Mullerian hormone, and inhibin B levels correlated significantly with therapy i
132                                      FSH and inhibin B levels correlated with menstrual status.
133                               Although serum inhibin B levels were increased overall in low-dose anim
134                                Neither serum inhibin B nor FSH is a suitable surrogate for determinat
135  secretion, indicating a status of pituitary inhibin B resistance.
136                                              Inhibin B was dichotomized as </= 31 ng/L or more than 3
137                        His markedly elevated inhibin B was unable to inhibit FSH secretion, indicatin
138          Gonadal function recovery, AMH, and inhibin B were assessed in the patients of childbearing
139 is was performed and serum levels of FSH and inhibin B were measured in 275 adult male survivors of c
140                   Age less than 45 years and inhibin B were significant multivariable baseline predic
141 n type IB receptor, ALK4, and participate in inhibin B's antagonism of activin signaling.
142 e changes were not observed; rather FSH, LH, inhibin B, and anti-Mullerian hormone were temporally al
143 ts of testicular volume, serum testosterone, inhibin B, and gonadotropins in these men with the resul
144   Serum samples were analysed for inhibin A, inhibin B, pro alpha C, and activin A.
145                      In contrast, TGFBR3L is inhibin B-specific and selectively expressed in gonadotr
146 inal fluid concentration and increases serum Inhibin-B and anti-Mullerian-hormone levels, but semen q
147                                 Activins and inhibins belong to the transforming growth factor beta (
148 ligands are formed from two disulfide-linked inhibin beta (Inhbeta) subunit chains.
149 ers (RREs), including an element upstream to inhibin beta A (inhba), a known effector of vertebrate r
150                 In this study, we identified inhibin beta A (or Inhba) as a regional paracrine factor
151 evels and intra-testicular inhibin alpha and inhibin beta B levels are not altered in the Six5 mutant
152                              In humans, rare Inhibin beta E (INHBE, activin E) loss-of-function varia
153 y and gene ontology (GO) analysis identified inhibin beta-B (Inhbb), an activin subunit and member of
154                                          The inhibin beta-subunit interacts with the activin type II
155                                              Inhibin, beta, which is also known as INHBA, encodes a p
156 a calcium/phosphate homeostatic hormone; and inhibin-beta B, a TGF-beta-like factor.
157               Amphiregulin, follistatin, and inhibin-beta-A and epiregulin were activated by an autoc
158 rticularly COX-2, amphiregulin, follistatin, inhibin-beta-A, and CYR61.
159  identified; pro-inhibin betaA and processed inhibin betaA (which dimerizes to activin A) were produc
160   Growing GCT cells expressed high levels of inhibin betaA and nuclear SMAD3, and the proliferation r
161 ules novel to cartilage were identified; pro-inhibin betaA and processed inhibin betaA (which dimeriz
162 e introduced mutations in the context of the inhibin betaA cDNA and assessed the signaling activity o
163 icate that the translational upregulation of inhibin betaA enhances the migration and invasion of cel
164 rotein expression and secreted levels of the inhibin betaA homodimer, activin A.
165                          One such transcript inhibin betaA is a member of the TGFbeta superfamily.
166     Here, we show by polysome profiling that inhibin betaA is translationally regulated by TGFbeta vi
167 ckdown of hnRNP E1 relieves silencing of the inhibin betaA transcript, resulting in increased protein
168 male mice in which both alleles encoding the inhibin betaB subunit have been deleted are unable to nu
169                     Our results suggest that inhibin betaE is a liver-expressed negative regulator of
170 site is within the betaglycan ZP domain, but inhibin binding is not integral to the ZP motif of other
171                     Recently, betaglycan and inhibin binding protein (InhBP/p120, also known as the p
172 eceptor, cause the disruption of activin and inhibin binding to ActRII.
173 h necessary and sufficient for high affinity inhibin binding.
174  betaglycan extracellular domain as the only inhibin-binding region in betaglycan.
175 nhBP/p120 does not play an essential role in inhibin biology.
176 hat BMP signaling might also be sensitive to inhibin blockade.
177                            Here we show that inhibin blocks cellular responses to diverse BMP family
178                   Activin stimulates whereas inhibin blocks follicle-stimulating hormone biosynthesis
179 e eluted from the column that bind iodinated inhibin but not iodinated activin.
180             InhBP/p120 may not directly bind inhibins but may interact with the activin type IB recep
181 eta receptor, betaglycan, can function as an inhibin co-receptor with ActRII.
182                                              Inhibin competes with BMPs for type II activin receptors
183                                 Activins and inhibins compose a heterogeneous subfamily within the tr
184                                              Inhibin concentrations are high in follicular fluid (FF)
185 gene 1 [IGSF1]) were identified as candidate inhibin coreceptors, shedding light on the molecular bas
186 tability of down-regulated let-7a targets in inhibin-deficient mice (Inha-/-).
187 les, whereas the affinity of the heterodimer inhibin does not.
188                           MIS receptor/alpha-inhibin double mutant males developed testicular stromal
189 e identical in phenotype to MIS ligand/alpha-inhibin double mutant males.
190                                              Inhibins fail to antagonize activin in some tissues and
191 the affinities of activin and its antagonist inhibin for ActRIIb-ECD and found that the affinity of t
192         Betaglycan increases the affinity of inhibins for the activin type IIA (ACVR2) receptor, ther
193 rly during the evolution of the hormone, and inhibin function is decreased by an antibody directed ag
194 GF-beta2 near normal fusion, but activin and inhibin had no effect.
195  both ActRII and ALK4 by each subunit of the inhibin heterodimer, in conjunction with the co-receptor
196 ing a similar beta-subunit, the secretion of inhibin heterodimers (alpha/beta) or activin homodimers
197 type II receptor BMPRII, which does not bind inhibin in the absence of betaglycan.
198                                              Inhibin, in concert with its co-receptor, betaglycan, ca
199 ); the betaB subunit of the hormone known as inhibin; interleukin-2 enhancer binding factor; an endop
200                                              Inhibin is a heterodimeric peptide hormone produced in t
201 nd serum tumor markers such as estradiol and inhibin is reasonable.
202 -antagonist relationship between activin and inhibin is unique and critical to integrated reproductiv
203 of gonadotropin-regulating proteins known as inhibins, is a tumor suppressor for testicular stromal c
204 6 mouse ovaries under direction of the alpha-inhibin large promoter.
205                             Serum CA-125 and inhibin levels were normal.
206 shedding light on the molecular basis of how inhibins may affect target cells.
207  inhibin-alpha-neutralizing Abs that prevent inhibin-mediated down-regulation of activin-induced pitu
208                                              Inhibin-null (INH(-/-)) mice develop gonadal tumors and-
209 may modulate the opposing effects of BMP and inhibin on androgen production.
210 line, we analyzed the effects of activin and inhibin on human erythroid differentiation.
211 s not known whether genetic variation in the inhibin pathway also influences susceptibility to testic
212 cleotide polymorphisms (SNP) in genes in the inhibin pathway among participants in the U.S. Serviceme
213  high tumor uptake in PC-3 or PC-3 prostatic inhibin peptide (PIP) tumor-bearing mice.
214  that distinct, though related, activins and inhibins perform unique functions and are not able to co
215 n synergizes with SF-1 to activate the alpha-inhibin promoter through formation of a transcriptional
216 ized with beta-catenin to activate the alpha-inhibin promoter through functional and physical interac
217 pport a cooperative model of binding for the inhibin receptor (ActRII.sTbetaRIII complex) but not for
218 d in this paper indicate that an independent inhibin receptor exists.
219 an)-Fc reconstituted a soluble high affinity inhibin receptor.
220 nt mice, were also identified as a source of inhibin receptor.
221 as been well characterized as a TGF-beta and inhibin receptor.
222 nd signaling pathways, little is known about inhibin receptors or the mechanism by which this molecul
223 embrane proteins were purified, and putative inhibin receptors were isolated using an inhibin affinit
224                        Although activins and inhibins regulate follicle-stimulating hormone (FSH) syn
225                        Betaglycan can confer inhibin responsiveness on cells that are otherwise insen
226                  Finally, betaglycan confers inhibin sensitivity to cell lines that otherwise respond
227 ceptor that regulates TGF-beta, activin, and inhibin signaling.
228 during puberty and pregnancy require activin/inhibin signalling from the stroma.
229 receptor but also require the presence of an inhibin-specific binding component.
230           Numerous tissues were examined for inhibin-specific binding sites, including the developing
231                      These data suggest that inhibin-specific membrane-associated proteins (receptors
232                                 Activins and inhibins, structurally related members of the TGF-beta s
233              We found that the expression of inhibin subunit beta A (inhba) and junB proto-oncogene (
234 he transforming growth factor beta 1 (TGFB1)/inhibin subunit beta A (INHBA) homodimer/Nodal-SMAD2/3 s
235                             HSF1 upregulated inhibin subunit beta A and thrombospondin 2, which were
236 n situ hybridization have shown that activin/inhibin subunits alpha, betaA, and betaB; receptors II a
237  mechanism where the regulation of furin and inhibin subunits cooperates in an important positive sho
238                   Expression patterns of the inhibin subunits, follistatin, FSTL3, Bambi, Cripto, and
239                                      Gonadal inhibins suppress FSH synthesis by pituitary gonadotrope
240                      Betaglycan also enables inhibin to bind to and compete with BMPs for binding to
241 ratory effects of inhibin and the ability of inhibin to repress matrix metalloproteinase levels in th
242 l significance, we examined ER expression in inhibin transgenic mice that have decreased activin expr
243 eromeric complex of type II, type I, and for inhibin, type III receptors.
244 p) TGF-beta2, rh TGF-beta3, rh activin, or p inhibin was added to the medium in different concentrati
245                             Betaglycan binds inhibin with high affinity and enhances binding in cells
246 beta-glycan, binds all 3 TGFbeta ligands and inhibin with high affinity but lacks the serine/threonin

 
Page Top